Jingjing Wu

707 total citations
27 papers, 535 citations indexed

About

Jingjing Wu is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Jingjing Wu has authored 27 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Biochemistry. Recurrent topics in Jingjing Wu's work include Eicosanoids and Hypertension Pharmacology (6 papers), Receptor Mechanisms and Signaling (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Jingjing Wu is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (6 papers), Receptor Mechanisms and Signaling (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Jingjing Wu collaborates with scholars based in China, Saint Kitts and Nevis and Australia. Jingjing Wu's co-authors include Wei Wei, Wu‐Yi Sun, Yanyan Zhao, Sen Zhang, Xiaoliang Liu, Xiupeng Zhang, Xiaoying Zheng, Enhua Wang, Qiang Han and Xuezhu Rong and has published in prestigious journals such as Gene, Molecular Endocrinology and The Journal of Pathology.

In The Last Decade

Jingjing Wu

26 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingjing Wu China 14 309 112 64 63 55 27 535
Zhengwen Jiang China 14 308 1.0× 93 0.8× 34 0.5× 47 0.7× 90 1.6× 30 685
Shanhong Lu China 13 254 0.8× 132 1.2× 53 0.8× 67 1.1× 58 1.1× 24 647
Dominga Latorre Italy 12 454 1.5× 140 1.3× 30 0.5× 34 0.5× 71 1.3× 12 716
Kaushala S. Jayawardana Australia 10 384 1.2× 98 0.9× 75 1.2× 100 1.6× 46 0.8× 12 654
Olga Bushueva Russia 19 300 1.0× 58 0.5× 62 1.0× 97 1.5× 30 0.5× 76 716
Guoguo Shang China 10 275 0.9× 71 0.6× 28 0.4× 51 0.8× 88 1.6× 15 496
Omar Motiño Spain 16 253 0.8× 102 0.9× 32 0.5× 43 0.7× 55 1.0× 31 561
Juan L. García‐Rodríguez Spain 10 298 1.0× 103 0.9× 43 0.7× 55 0.9× 80 1.5× 20 511
Jiexia Ding China 10 224 0.7× 169 1.5× 73 1.1× 66 1.0× 32 0.6× 16 539
Gene Hsiao United States 7 415 1.3× 89 0.8× 48 0.8× 57 0.9× 87 1.6× 9 710

Countries citing papers authored by Jingjing Wu

Since Specialization
Citations

This map shows the geographic impact of Jingjing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Wu more than expected).

Fields of papers citing papers by Jingjing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Wu. The network helps show where Jingjing Wu may publish in the future.

Co-authorship network of co-authors of Jingjing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Wu. A scholar is included among the top collaborators of Jingjing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Wu. Jingjing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jingjing, et al.. (2024). Surface-enhanced Raman scattering on nanomaterials for cancer and pathogens diagnosis. Nano Research. 18(2). 94907096–94907096. 5 indexed citations
2.
Chen, Zhihui, Yajun Tao, Yang Xu, et al.. (2024). Efficient Breeding of Early-Maturing Rice Cultivar by Editing Hd6 via CRISPR/Cas9. Rice Science. 31(6). 629–633. 1 indexed citations
3.
Bao, Hairong, Changyuan Wang, Yue Jin, et al.. (2024). The contributory role of GSK3β in hypertension exacerbating atherosclerosis by regulating the OMA1/PGC1α pathway. APOPTOSIS. 30(1-2). 117–130.
4.
Li, Nan, Jingjing Wu, Meng Qi, et al.. (2022). CP-25 exerts a protective effect against ConA-induced hepatitis via regulating inflammation and immune response. Frontiers in Pharmacology. 13. 1041671–1041671. 2 indexed citations
5.
Wu, Jingjing, et al.. (2021). Renal NKCC2 Is Dual Regulated by the Synergy of 20-HETE and High-Fat Diet in CYP4F2 Transgenic Mice. Kidney & Blood Pressure Research. 46(5). 601–612. 3 indexed citations
7.
Li, Nan, Jingjing Wu, Tingting Chen, et al.. (2020). <p>GRK2 Suppresses Hepatocellular Carcinoma Metastasis and Invasion Through Down-Regulation of Prostaglandin E Receptor 2</p>. OncoTargets and Therapy. Volume 13. 9559–9571. 4 indexed citations
8.
Chen, Fangjie, et al.. (2018). miR-125a Suppresses TrxR1 Expression and Is Involved in H2O2-Induced Oxidative Stress in Endothelial Cells. Journal of Immunology Research. 2018. 1–7. 17 indexed citations
9.
Wu, Jingjing, Xiupeng Zhang, Qiang Han, et al.. (2018). ZNF326 promotes proliferation of non-small cell lung cancer cells by regulating ERCC1 expression. Laboratory Investigation. 99(2). 169–179. 9 indexed citations
10.
Sun, Wu‐Yi, et al.. (2018). The role of G protein-coupled receptor kinases in the pathology of malignant tumors. Acta Pharmacologica Sinica. 39(11). 1699–1705. 20 indexed citations
11.
Zhang, Xiupeng, Guiyang Jiang, Jingjing Wu, et al.. (2018). Zinc finger protein 668 suppresses non-small cell lung cancer invasion and migration by downregulating Snail and upregulating E-cadherin and zonula occludens-1. Oncology Letters. 15(3). 3806–3813. 5 indexed citations
12.
Sun, Ru, et al.. (2017). 20-HETE regulated PSMB5 expression via TGF-β/Smad signaling pathway. Prostaglandins & Other Lipid Mediators. 134. 123–130. 10 indexed citations
14.
Wu, Jingjing, et al.. (2017). Elevated microRNA-520g in pre-eclampsia inhibits migration and invasion of trophoblasts. Placenta. 51. 70–75. 42 indexed citations
15.
Zheng, Xiaoying, Qianze Dong, Xiupeng Zhang, et al.. (2017). The coiled-coil domain of oncogene RASSF 7 inhibits hippo signaling and promotes non-small cell lung cancer. Oncotarget. 8(45). 78734–78748. 12 indexed citations
16.
Sun, Wu‐Yi, et al.. (2015). The emerging roles of β-arrestins in fibrotic diseases. Acta Pharmacologica Sinica. 36(11). 1277–1287. 42 indexed citations
17.
Zhang, Sen, Wu‐Yi Sun, Jingjing Wu, & Wei Wei. (2014). TGF-β signaling pathway as a pharmacological target in liver diseases. Pharmacological Research. 85. 15–22. 34 indexed citations
18.
Huang, Guoliang, Binbin Li, Jingjing Wu, et al.. (2013). Prolyl Isomerase Pin1 Regulated Signaling Pathway Revealed by Pin1 +/+ and Pin1 −/− Mouse Embryonic Fibroblast Cells. Pathology & Oncology Research. 19(4). 667–675. 4 indexed citations
19.
Hu, Shanshan, Di Wang, Jingjing Wu, et al.. (2012). Involvement of β-arrestins in cancer progression. Molecular Biology Reports. 40(2). 1065–1071. 19 indexed citations
20.
Wu, Jingjing, et al.. (2012). Synergistical effect of 20-HETE and high salt on NKCC2 protein and blood pressure via ubiquitin–proteasome pathway. Human Genetics. 132(2). 179–187. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026